Damage-associated molecular patterns in vitiligo: igniter fuse from oxidative stress to melanocyte loss

References

• Ezzedine K, Eleftheriadou V, Whitton M, et al. Vitiligo. The Lancet. 2015;386(9988):74–84.
   PubMed Web of Science ®Google Scholar
• Dabas G, Vinay K, Parsad D, et al. Psychological disturbances in patients with pigmentary disorders: a cross-sectional study. J Eur Acad Dermatol Venereol. 2020 Feb;34(2):392–399.
   PubMed Web of Science ®Google Scholar
• Bergqvist C, Ezzedine K. Vitiligo: A focus on pathogenesis and its therapeutic implications. J Dermatol. 2021 Mar;48(3):252–270.
   PubMed Web of Science ®Google Scholar
• Bergqvist C, Ezzedine K. Vitiligo: A Review. Dermatology. 2020;236(6):571–592.
   PubMed Web of Science ®Google Scholar
• Xuan Y, Yang Y, Xiang L, et al. The Role of Oxidative Stress in the Pathogenesis of Vitiligo: A Culprit for Melanocyte Death. Oxid Med Cell Longev. 2022;2022:8498472.
   PubMed Web of Science ®Google Scholar
• Li S, Zhu G, Yang Y, et al. Oxidative stress drives CD8(+) T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes. J Allergy Clin Immunol. 2017 Jul;140(1):177–189. e9.
   PubMed Web of Science ®Google Scholar
• Roh JS, Sohn DH. Damage-Associated Molecular Patterns in Inflammatory Diseases. Immune Netw. 2018 Aug;18(4):e27.
   PubMed Web of Science ®Google Scholar
• Bertero E, Maack C. Calcium Signaling and Reactive Oxygen Species in Mitochondria. Circ Res. 2018 May 11;122(10):1460–1478.
   PubMed Web of Science ®Google Scholar
• Mathachan SR, Khurana A, Gautam RK, et al. Does oxidative stress correlate with disease activity and severity in vitiligo? An analytical study. J Cosmet Dermatol. 2021 Jan;20(1):352–359.
   PubMed Web of Science ®Google Scholar
• Huchzermeyer B, Menghani E, Khardia P, et al. Metabolic Pathway of Natural Antioxidants, Antioxidant Enzymes and ROS Providence. Antioxidants (Basel). 2022 Apr 11;11(4):761.
   PubMedGoogle Scholar
• Speeckaert R, Dugardin J, Lambert J, et al. Critical appraisal of the oxidative stress pathway in vitiligo: a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2018 Jul;32(7):1089–1098.
   PubMed Web of Science ®Google Scholar
• Huo J, Liu T, Huan Y, et al. Serum level of antioxidant vitamins and minerals in patients with vitiligo, a systematic review and meta-analysis. J Trace Elem Med Biol. 2020 Dec;62:126570.
   PubMed Web of Science ®Google Scholar
• Liu S, Pi J, Zhang Q. Mathematical modeling reveals quantitative properties of KEAP1-NRF2 signaling. Redox Biol. 2021 Sep 22;47:102139.
   PubMed Web of Science ®Google Scholar
• Qiu L, Song Z, Setaluri V. Oxidative stress and vitiligo: the Nrf2-ARE signaling connection. J Invest Dermatol. 2014 Aug;134(8):2074–2076.
   PubMed Web of Science ®Google Scholar
• Zhou S, Zeng H, Huang J, et al. Epigenetic regulation of melanogenesis. Ageing Res Rev. 2021 Aug;69:101349.
   PubMed Web of Science ®Google Scholar
• Zindel J, Kubes P. DAMPs, PAMPs, and LAMPs in Immunity and Sterile Inflammation. Annu Rev Pathol. 2020 Jan 24;15:493–518.
   PubMed Web of Science ®Google Scholar
• Gong T, Liu L, Jiang W, et al. DAMP-sensing receptors in sterile inflammation and inflammatory diseases. Nat Rev Immunol. 2020 Feb;20(2):95–112.
   PubMed Web of Science ®Google Scholar
• Yang HZ, Oppenheim JJ. Alarmins and immunity. Immunol Rev. 2017 Nov;280(1):41–56.
   PubMed Web of Science ®Google Scholar
• Hudson BI, Lippman ME. Targeting RAGE Signaling in Inflammatory Disease. Annu Rev Med. 2018 Jan 29;69:349–364.
   PubMed Web of Science ®Google Scholar
• Sarrand J, Baglione L, Parisis D, et al. The Involvement of Alarmins in the Pathogenesis of Sjogren's Syndrome. Int J Mol Sci. 2022 May 18;23(10):5671.
   Web of Science ®Google Scholar
• Satoh TK. The role of HMGB1 in inflammatory skin diseases. J Dermatol Sci. 2022 Jul 13. doi:10.1016/j.jdermsci.2022.07.005.
   PubMed Web of Science ®Google Scholar
• Andersson U, Tracey KJ, Yang H. Post-Translational Modification of HMGB1 Disulfide Bonds in Stimulating and Inhibiting Inflammation. Cells. 2021 Nov 26;10(12):3323.
   Web of Science ®Google Scholar
• Murai S, Yamaguchi Y, Shirasaki Y, et al. A FRET biosensor for necroptosis uncovers two different modes of the release of DAMPs. Nat Commun. 2018 Oct 26;9(1):4457.
   PubMedGoogle Scholar
• Deng M, Tang Y, Li W, et al. The Endotoxin Delivery Protein HMGB1 Mediates Caspase-11-Dependent Lethality in Sepsis. Immunity. 2018 Oct 16;49(4):740–753. e7.
   PubMed Web of Science ®Google Scholar
• Raucci A, Di Maggio S, Scavello F, et al. The Janus face of HMGB1 in heart disease: a necessary update. Cell Mol Life Sci. 2019 Jan;76(2):211–229.
   PubMed Web of Science ®Google Scholar
• Kaur I, Behl T, Bungau S, et al. Exploring the therapeutic promise of targeting HMGB1 in rheumatoid arthritis. Life Sci. 2020 Oct 1;258:118164.
   PubMed Web of Science ®Google Scholar
• Cui T, Zhang W, Li S, et al. Oxidative Stress-Induced HMGB1 Release from Melanocytes: A Paracrine Mechanism Underlying the Cutaneous Inflammation in Vitiligo. J Invest Dermatol. 2019 Oct;139(10):2174–2184. e4.
   PubMed Web of Science ®Google Scholar
• Mou K, Liu W, Miao Y, et al. HMGB1 deficiency reduces H2 O2 -induced oxidative damage in human melanocytes via the Nrf2 pathway. J Cell Mol Med. 2018 Dec;22(12):6148–6156.
   PubMed Web of Science ®Google Scholar
• Kim JY, Lee EJ, Seo J, et al. Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo. Br J Dermatol. 2017 Jun;176(6):1558–1568.
   PubMed Web of Science ®Google Scholar
• Zhang K, Anumanthan G, Scheaffer S, et al. HMGB1/RAGE Mediates UVB-Induced Secretory Inflammatory Response and Resistance to Apoptosis in Human Melanocytes. J Invest Dermatol. 2019 Jan;139(1):202–212.
   PubMed Web of Science ®Google Scholar
• Rosenzweig R, Nillegoda NB, Mayer MP, et al. The Hsp70 chaperone network. Nat Rev Mol Cell Biol. 2019 Nov;20(11):665–680.
   PubMed Web of Science ®Google Scholar
• Pockley AG, Henderson B. Extracellular cell stress (heat shock) proteins-immune responses and disease: an overview. Philos Trans R Soc Lond B Biol Sci. 2018 Jan 19;373(1738):0522.
   Google Scholar
• Veglia F, Tyurin VA, Mohammadyani D, et al. Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer. Nat Commun. 2017 Dec 14;8(1):2122.
   PubMedGoogle Scholar
• Tukaj S. Heat Shock Protein 70 as a Double Agent Acting Inside and Outside the Cell: Insights into Autoimmunity. Int J Mol Sci. 2020 Jul 26;21(15):5298.
   PubMed Web of Science ®Google Scholar
• Moin ASM, Nandakumar M, Diane A, et al. The Role of Heat Shock Proteins in Type 1 Diabetes. Front Immunol. 2020;11:612584.
   PubMed Web of Science ®Google Scholar
• van Eden W, Jansen MAA, Ludwig IS, et al. Heat Shock Proteins Can Be Surrogate Autoantigens for Induction of Antigen Specific Therapeutic Tolerance in Rheumatoid Arthritis. Front Immunol. 2019;10:279.
   PubMed Web of Science ®Google Scholar
• Abdou AG, Maraee AH, Reyad W. Immunohistochemical expression of heat shock protein 70 in vitiligo. Ann Diagn Pathol. 2013 Jun;17(3):245–249.
   PubMed Web of Science ®Google Scholar
• Mosenson JA, Flood K, Klarquist J, et al. Preferential secretion of inducible HSP70 by vitiligo melanocytes under stress. Pigment Cell Melanoma Res. 2014 Mar;27(2):209–220.
   PubMed Web of Science ®Google Scholar
• Hariharan V, Klarquist J, Reust MJ, et al. Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation. J Invest Dermatol. 2010 Jan;130(1):211–220.
   PubMed Web of Science ®Google Scholar
• Jacquemin C, Rambert J, Guillet S, et al. Heat shock protein 70 potentiates interferon alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis. Br J Dermatol. 2017 Nov;177(5):1367–1375.
   PubMed Web of Science ®Google Scholar
• Denman CJ, McCracken J, Hariharan V, et al. HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. J Invest Dermatol. 2008 Aug;128(8):2041–2048.
   PubMed Web of Science ®Google Scholar
• Mosenson JA, Zloza A, Klarquist J, et al. HSP70i is a critical component of the immune response leading to vitiligo. Pigment Cell Melanoma Res. 2012 Jan;25(1):88–98.
   PubMed Web of Science ®Google Scholar
• Mosenson JA, Zloza A, Nieland JD, et al. Mutant HSP70 reverses autoimmune depigmentation in vitiligo. Sci Transl Med. 2013 Feb 27;5(174):174ra28.
   PubMed Web of Science ®Google Scholar
• Henning SW, Fernandez MF, Mahon JP, et al. HSP70iQ435A-Encoding DNA Repigments Vitiligo Lesions in Sinclair Swine. J Invest Dermatol. 2018 Dec;138(12):2531–2539.
   PubMed Web of Science ®Google Scholar
• Frisoli ML, Harris JE. Treatment with Modified Heat Shock Protein Repigments Vitiligo Lesions in Sinclair Swine. J Invest Dermatol. 2018 Dec;138(12):2505–2506.
   PubMed Web of Science ®Google Scholar
• Gonzalez LL, Garrie K, Turner MD. Role of S100 proteins in health and disease. Biochim Biophys Acta Mol Cell Res. 2020 Jun;1867(6):118677.
   PubMed Web of Science ®Google Scholar
• Gross SR, Sin CGT, Barraclough R, et al. Joining S100 proteins and migration: for better or for worse, in sickness and in health. Cell Mol Life Sci. 2013;71(9):1551–1579.
   PubMed Web of Science ®Google Scholar
• Xia C, Braunstein Z, Toomey AC, et al. S100 Proteins As an Important Regulator of Macrophage Inflammation. Front Immunol. 2018;8:01908.
   PubMed Web of Science ®Google Scholar
• Turnier JL, Fall N, Thornton S, et al. Urine S100 proteins as potential biomarkers of lupus nephritis activity. Arthritis Res Ther. 2017 Oct 24;19(1):242.
   PubMedGoogle Scholar
• Birlea SA. S100B: Correlation with Active Vitiligo Depigmentation. J Invest Dermatol. 2017 Jul;137(7):1408–1410.
   PubMed Web of Science ®Google Scholar
• Shabaka FH, Rashed LA, Said M, et al. Sensitivity of serum S100B protein as a disease activity marker in Egyptian patients with vitiligo (case-control study). Arch Physiol Biochem. 2020 Mar 19;8:1–8.
   Web of Science ®Google Scholar
• Speeckaert R, Voet S, Hoste E, et al. S100B Is a Potential Disease Activity Marker in Nonsegmental Vitiligo. J Invest Dermatol. 2017;137(7):1445–1453.
   PubMed Web of Science ®Google Scholar
• Tomas-Velazquez A, Lopez-Gutierrez JC, Ceballos C, et al. S-100B serum protein is elevated in children with medium-to-giant congenital melanocytic nevi: An exploratory case-control study. J Am Acad Dermatol. 2020 Jul;83(1):222–224.
   PubMed Web of Science ®Google Scholar
• Leclerc E, Fritz G, Weibel M, et al. S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem. 2007 Oct 26;282(43):31317–31331.
   PubMed Web of Science ®Google Scholar
• Vercellino I, Sazanov LA. The assembly, regulation and function of the mitochondrial respiratory chain. Nat Rev Mol Cell Biol. 2021 Oct 7;23(2):141–161.
   PubMed Web of Science ®Google Scholar
• Giuliani AL, Sarti AC, Di Virgilio F. Extracellular nucleotides and nucleosides as signalling molecules. Immunol Lett. 2019 Jan;205:16–24.
   PubMed Web of Science ®Google Scholar
• Savio LEB, Leite-Aguiar R, Alves VS, et al. Purinergic signaling in the modulation of redox biology. Redox Biol. 2021 Sep 22;47:102137.
   PubMed Web of Science ®Google Scholar
• Di Virgilio F, Sarti AC, Falzoni S, et al. Extracellular ATP and P2 purinergic signalling in the tumour microenvironment. Nat Rev Cancer. 2018 Oct;18(10):601–618.
   PubMed Web of Science ®Google Scholar
• Wang W, Hu D, Feng Y, et al. Paxillin mediates ATP-induced activation of P2X7 receptor and NLRP3 inflammasome. BMC Biol. 2020 Nov 26;18(1):182.
   PubMed Web of Science ®Google Scholar
• Li Z, Gu Y, Wen R, et al. Lysosome exocytosis is involved in astrocyte ATP release after oxidative stress induced by H2O2. Neurosci Lett. 2019;705:251–258.
   PubMed Web of Science ®Google Scholar
• Srisomboon Y, Ohkura N, Iijima K, et al. Airway Exposure to Polyethyleneimine Nanoparticles Induces Type 2 Immunity by a Mechanism Involving Oxidative Stress and ATP Release. Int J Mol Sci. 2021;22(16):9071.
   PubMed Web of Science ®Google Scholar
• Di Virgilio F, Dal Ben D, Sarti AC, et al. The P2X7 Receptor in Infection and Inflammation. Immunity. 2017 Jul 18;47(1):15–31.
   PubMed Web of Science ®Google Scholar
• Riteau N, Baron L, Villeret B, et al. ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation. Cell Death Dis. 2012;3(10):e403–e403.
   PubMedGoogle Scholar
• Rogers C, Erkes DA, Nardone A, et al. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation. Nat Commun. 2019 Apr 11;10(1):1689.
   PubMed Web of Science ®Google Scholar
• Di A, Xiong S, Ye Z, et al. The TWIK2 Potassium Efflux Channel in Macrophages Mediates NLRP3 Inflammasome-Induced Inflammation. Immunity. 2018 Jul 17;49(1):56–65. e4.
   PubMed Web of Science ®Google Scholar
• Dell'Anna ML, Ottaviani M, Kovacs D, et al. Energetic mitochondrial failing in vitiligo and possible rescue by cardiolipin. Sci Rep. 2017 Oct 20;7(1):13663.
   PubMedGoogle Scholar
• Xu P, Xue YN, Ji HH, et al. H2 O2 -induced oxidative stress disrupts mitochondrial functions and impairs migratory potential of human epidermal melanocytes. Exp Dermatol. 2020 Aug;29(8):733–741.
   PubMed Web of Science ®Google Scholar
• Atwa MA, Ali SMM, Youssef N, et al. Elevated serum level of interleukin-15 in vitiligo patients and its correlation with disease severity but not activity. J Cosmet Dermatol. 2020;20(8):2640–2644.
   PubMed Web of Science ®Google Scholar
• Chen X, Guo W, Chang Y, et al. Oxidative stress-induced IL-15 trans-presentation in keratinocytes contributes to CD8+ T cells activation via JAK-STAT pathway in vitiligo. Free Radical Biol Med. 2019;139:80–91.
   PubMed Web of Science ®Google Scholar
• Adachi T, Kobayashi T, Sugihara E, et al. Hair follicle-derived IL-7 and IL-15 mediate skin-resident memory T cell homeostasis and lymphoma. Nat Med. 2015 Nov;21(11):1272–1279.
   PubMed Web of Science ®Google Scholar
• <Antibody blockade of IL-15 signaling has the potential to durably reverse vitiligo..pdf>.
   Google Scholar
• Zhong Z, Su G, Kijlstra A, et al. Activation of the interleukin-23/interleukin-17 signalling pathway in autoinflammatory and autoimmune uveitis. Prog Retin Eye Res. 2021 Jan;80:100866.
   PubMed Web of Science ®Google Scholar
• Speeckaert R, Speeckaert M, De Schepper S, et al. Biomarkers of disease activity in vitiligo: A systematic review. Autoimmun Rev. 2017 Sep;16(9):937–945.
   PubMed Web of Science ®Google Scholar
• Acharya P, Mathur M. Interleukin-17 level in patients with vitiligo: A systematic review and meta-analysis. Australas J Dermatol. 2020 May;61(2):e208–e212.
   PubMed Web of Science ®Google Scholar
• Bhardwaj S, Rani S, Kumaran MS, et al. Expression of Th17- and Treg-specific transcription factors in vitiligo patients. Int J Dermatol. 2020 Apr;59(4):474–481.
   PubMed Web of Science ®Google Scholar
• Kotobuki Y, Tanemura A, Yang L, et al. Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris. Pigment Cell Melanoma Res. 2012 Mar;25(2):219–230.
   PubMed Web of Science ®Google Scholar
• Li P, Ma H, Han D, et al. Interleukin-33 affects cytokine production by keratinocytes in vitiligo. Clinical & Experimental Dermatology. 2015;40(2):163–170.
   PubMed Web of Science ®Google Scholar
• Vaccaro M, Cicero F, Mannucci C, et al. IL-33 circulating serum levels are increased in patients with non-segmental generalized vitiligo. Arch Dermatol Res. 2016;308(7):527–530.
   PubMed Web of Science ®Google Scholar
• Magana M, Pushpanathan M, Santos AL, et al. The value of antimicrobial peptides in the age of resistance. Lancet Infect Dis. 2020;20(9):e216–e230.
   PubMed Web of Science ®Google Scholar
• Gan BH, Gaynord J, Rowe SM, et al. The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions. Chem Soc Rev. 2021;50(13):7820–7880.
   PubMed Web of Science ®Google Scholar
• Mookherjee N, Anderson MA, Haagsman HP, et al. Antimicrobial host defence peptides: functions and clinical potential. Nat Rev Drug Discov. 2020 May;19(5):311–332.
   PubMed Web of Science ®Google Scholar
• Deng Z, Chen M, Liu Y, et al. A positive feedback loop between mTORC1 and cathelicidin promotes skin inflammation in rosacea. EMBO Mol Med. 2021 May 7;13(5):e13560.
   PubMed Web of Science ®Google Scholar
• Nguyen HLT, Trujillo-Paez JV, Umehara Y, et al. Role of Antimicrobial Peptides in Skin Barrier Repair in Individuals with Atopic Dermatitis. Int J Mol Sci. 2020 Oct 14;21(20):7607.
   Web of Science ®Google Scholar
• Zhang LJ, Sen GL, Ward NL, et al. Antimicrobial Peptide LL37 and MAVS Signaling Drive Interferon-beta Production by Epidermal Keratinocytes during Skin Injury. Immunity. 2016 Jul 19;45(1):119–130.
   PubMed Web of Science ®Google Scholar
• Liang H, Yan Y, Wu J, et al. Topical nanoparticles interfering with the DNA-LL37 complex to alleviate psoriatic inflammation in mice and monkeys. Sci Adv. 2020 Jul;6(31):eabb5274.
   PubMed Web of Science ®Google Scholar
• Frisoli ML, Essien K, Harris JE. Vitiligo: Mechanisms of Pathogenesis and Treatment. Annu Rev Immunol. 2020 Apr 26;38:621–648.
   PubMed Web of Science ®Google Scholar
• Atazadeh F, Fazeli Z, Vahidnezhad H, et al. Increased level of cathelicidin (LL-37) in vitiligo: Possible pathway independent from vitamin D receptor gene polymorphism. Exp Dermatol. 2020 Dec;29(12):1176–1185.
   PubMed Web of Science ®Google Scholar